|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 8 February 2006
doi: 10.1242/dev.02273
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
is required for lung maturation at birth
Division of Pulmonary Biology and Neonatology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
* Author for correspondence (e-mail: machiko.ikegami{at}cchmc.org)
Accepted 4 January 2006
| SUMMARY |
|---|
|
|
|---|
plays a crucial role in the maturation of the respiratory
epithelium in late gestation, being required for the production of surfactant
lipids and proteins necessary for lung function. Deletion of the
Cebpa gene in respiratory epithelial cells in fetal mice caused
respiratory failure at birth. Structural and biochemical maturation of the
lung was delayed. Normal synthesis of surfactant lipids and proteins,
including SP-A, SP-B, SP-C, SP-D, ABCA3 (a lamellar body associated protein)
and FAS (precursor of fatty acid synthesis) were dependent upon expression of
the C/EBP
in respiratory epithelial cells. Deletion of the
Cebpa gene caused increased expression of Tgfb2, a growth
factor that inhibits lung epithelial cell proliferation and differentiation.
Normal expression of C/EBP
required Titf1 and Foxa2,
transcription factors that also play an important role in perinatal lung
differentiation. C/EBP
participates in a transcriptional network that
is required for the regulation of genes mediating perinatal lung maturation
and surfactant homeostasis that is necessary for adaptation to air breathing
at birth.
Key words: CCAAT/enhancer-binding protein
, Respiratory epithelial cell differentiation, Lung maturation, Pulmonary surfactant, ABCA3, FOXA2, TTF1, Mouse
| INTRODUCTION |
|---|
|
|
|---|
C/EBP
(CCAAT enhancer binding protein
) is a member of a
family of basic leucine zipper (bZIP) transcription factors
(Alam et al., 1992
) that serves
an important role in normal tissue development, regulation of cell
proliferation and differentiation, lipid metabolism, and lipid biosynthesis
(Cao et al., 1991
;
De Simone and Cortese, 1992
;
Sugahara et al., 1999
;
Sugahara et al., 2001
).
Increased levels of C/EBP
mRNA were observed in tissues that have high
rates of synthesis of lipids and cholesterol-linked compounds, including
liver, fat, intestine, lung, adrenal gland and placenta
(Birkenmeier et al., 1989
;
Lekstrom-Himes and Xanthopoulos,
1998
; Takiguchi,
1998
). In fetal lung, C/EBP
expression was detected in
subsets of respiratory epithelial cells prior to birth and was abundantly
expressed in alveolar type II cells in the peripheral lung
(Li et al., 1995
). However,
elucidation of the roles of C/EBP
in postnatal lung development and
function was complicated by the precocious death of mice with a homozygous
null mutation in the Cebpa gene. Newborn
Cebpa/ pups die primarily from hypoglycemia
caused by liver dysfunction (Wang et al.,
1995
; Burgess-Beusse and
Darlington, 1998
); however, a subset exhibit clinical symptoms of
respiratory distress, displaying a primitive lung
(Flodby et al., 1996
;
Sugahara et al., 2001
). In
cultured type II epithelial cells, marked increases in C/EBP
mRNA and
protein were observed following exposure to FGF7, a growth factor that induces
proliferation and surfactant synthesis in the lung
(Cardoso et al., 1997
;
Yano et al., 2000
;
Mason et al., 2003
;
Portnoy et al., 2004
;
Zhang et al., 2004
). The
temporal-spatial expression of C/EBP
and its known function in lipid
metabolism provided a rationale supporting its role in respiratory epithelial
cell differentiation and surfactant homeostasis in the perinatal period. To
identify the potential roles of C/EBP
in lung morphogenesis and
function, we deleted the mouse Cebpa gene in respiratory epithelial
cells of the fetal lung using a conditional Cre/LoxP recombination system.
Deletion of Cebpa inhibited differentiation of the fetal lung,
causing death from respiratory failure at birth.
| MATERIALS AND METHODS |
|---|
|
|
|---|
/
mice, were generated by mating
(tetO)7CMV-Cre/tg/Cebpaflox/flox
to SP-C-rtTA/tg/Cebpaflox/flox.
Cebpaflox/flox littermates lacking either rtTA or Cre
genes served as controls. Genotypes were identified by PCR with genomic DNA
from the tails of fetal and postnatal mice using the forward primer
5'-CCA CTC ACC GCC TTG GAA AGT CAC A-3', the reverse primer
5'-CCG CGG CTC CAC CTC GTA GAA GTC G-3' and the knockout primer
5'-AGG GAC CTA ATA ACT TCG TAT AGC A-3' for
Cebpaflox/flox. Genotyping for SP-C-rtTA and
(tetO)7CMV-Cre DNA was performed by PCR as described previously
(Perl et al., 2002
/
mice in which Foxa2 was
selectively deleted from the respiratory epithelium were generated as
previously reported (Wan et al.,
2004
Animal husbandry and doxycycline administration
Animals were maintained in a pathogen-free environment in accordance with
protocols approved by the Institutional Animal Care and Use Committee of the
Cincinnati Children's Hospital Research Foundation. All animals were housed in
humidity- and temperature-controlled rooms on a 12 hour-12 hour light-dark
cycle. Mice were allowed food and water ad libitum. There was no serological
evidence of pulmonary pathogens or bacterial infections in sentinel mice
maintained within the colony. Gestation was dated by detection of the vaginal
plug (as E0.5) and correlated with weight of each pup at the time of
sacrifice. Dams bearing control and Cebpa
/
mice were maintained on doxycycline in food (625 mg/kg; Harlan Teklad,
Madison, WI) from E0. At E18.5, dams were killed by exsanguination and lungs
were dissected for analysis.
Blood glucose analysis
Glucose concentrations in neonatal blood were measured immediately upon
collection using Ascensia Elite Blood Glucose Meter (Model 9662A, Bayer) with
Ascensia Elite XL Blood Glucose Test Strips that have a 1.1-33.3
mmol/l (20-600 mg/dl) sensitivity.
Morphological analysis
Tissues from fetal lungs were fixed in situ after opening the chest and
immersion in 4% paraformaldehyde in PBS and processed into paraffin blocks.
Antibodies used for immunohistochemistry were: C/EBP
(1:5000, rabbit
polyclonal IgG, Santa Cruz Biotechnology, Santa Cruz, CA), FOXA1 (1:2000,
guinea pig polyclonal antibody) (Wan et
al., 2005
), TTF1 (1:5000, rabbit polyclonal)
(Wan et al., 2005
), mature
SP-B (1:1000, rabbit polyclonal) (Perl et
al., 2002
), pro-SP-C (1:2000, rabbit polyclonal AB3428, Chemicon,
Temecula, CA), AQP5 (aquaporin 5) (1:10, kindly provided by Dr Anil Menon),
vWF (von Willebrand Factor) (1:800, DAKO, Carpinteria, CA), PAS (Periodic Acid
Schiff) (K047, Poly Scientific R&D, Bay Shore, NY), TGFß2 (1:300,
rabbit polyclonal, Santa Cruz Biotechnology, Santa Cruz, CA) and
-SMA
(
-smooth muscle actin) (1:10,000, mouse monoclonal, clone IA4,
Sigma-Aldrich, St Louis, MO). Electron microscopy was performed on lung tissue
obtained from E18.5 Cebpa
/
mice and
littermate controls after fixation in glutaraldehyde
(Clark et al., 2001
). All
experiments shown are representative of findings from at least two independent
dams, generating at least four triple-transgenic offspring that were compared
with littermates.
RNA isolation and analysis
RNA was prepared by using TRIzol® Reagent (Invitrogen, Carlsbad, CA)
according to the manufacturer's specifications. Total RNA was isolated by
phenol-chloroform extraction and precipitation with isopropanol. A
spectrophotometer was used to measure total RNA concentration. Quantification
of surfactant protein (SP)-A, SP-B, SP-C and SP-D mRNAs was performed by S1
nuclease assays. C/EBP
, C/EBPß, C/EBP
and FOXA2 mRNAs were
quantified by RNase protection assays with ribosomal protein L32 as an
internal control (Dranoff et al.,
1994
). Rat FOXA2 cDNA probe was kindly provided by Dr R. Costa
(University of Illinois).
RNA microarray analysis
Methods for RNA isolation, amplification and data analysis are essentially
as described previously (Xu et al.,
2003
). Lung cRNA was hybridized to the murine genome MOE430
(consists of
45,000 gene entries) chips (Affymetrix, Santa Clara, CA)
according to the manufacturer's protocol. Affymetrix MICROARRAY SUITE 5.0 was
used to scan and quantitate the gene chips under default scan settings.
Normalization was performed using the three step Robust Multichip Average
Model (Irizarry et al., 2003a
;
Irizarry et al., 2003b
):
background adjustment, quartile normalization and summarization. Data were
further analyzed using Significance Analysis of Microarrays (SAM)
(Tusher et al., 2001
) and
Genespring 7.2 (Silicon Genetics, Redwood City, CA). Multiple criteria were
used to select differentially expressed genes conservatively. Detection of
differential expression was performed using random permutation and Welch's
approximate t-test for mutant and control groups at
P
0.01, False Discovery Rate (FDR)
10%, coefficient variation
<50%. Additional filters for positive candidate selection, including a
minimal twofold change in absolute ratio and a minimum 2-Present call by
Affymetrix algorithm in three samples with a relative higher expression, were
used. Gene Ontology (GO) analysis was performed using the publicly available
web-based tool, DAVID (Database for Annotation, Visualization, and Integrated
Discovery) (Dennis et al.,
2003
).
Surfactant lipid and protein analysis
The left lobe was homogenized in 0.9% NaCl and protease inhibitor (1:100)
(P 8340) (Sigma Chemical, St Louis, MO) was added to the lung homogenate (LH).
Saturated phosphatidylcholine (Sat PC) was isolated from lipid extracts of
lung homogenate using osmium tetroxide (OsO4)
(Mason et al., 1976
), followed
by measurement of phosphorous (Bartlett,
1959
). Phospholipid composition was determined after 2D thin-layer
chromatography (Ikegami et al.,
2003
). For SP-B and SP-C immunoblot analysis, extracted lipids of
lung homogenate (5% for SP-B, 10% for SP-C) were loaded on a SDS/PAGE gel and
transferred to nitrocellulose (0.10 µm) with antiserum against mature human
SP-B peptide (Chemicon, Temecula, CA) or high-titer anti-SP-C antibody, raised
against a modified human recombinant 34 amino acid SP-C peptide
(Glasser et al., 2001
).
Supernatant of lung homogenate (1500 g for 15 minutes) was
subjected to a SDS/PAGE gel to estimate the content of SP-A and SP-D. Resolved
proteins were transferred to a nitrocellulose membrane (0.45 µm) and
immunoblot analysis was performed with guinea pig anti-rat SP-A
(Ikegami et al., 2003
) or
rabbit anti-mouse SP-D (Stahlman et al.,
2002
) antiserum diluted in Tris-buffered saline with 0.1% Tween
(TBS-T). Goat anti-guinea pig IgG peroxidase-conjugate (Sigma, St Louis, MO)
was used for SP-A. Goat anti-rabbit (heavy and light chain)
peroxidase-conjugate (Calbiochem, La Jolla, CA) was used as the secondary
antibody for SP-B, SP-C and SP-D.
For identification of ABCA3 (ATP-binding cassette transporter 3), homogenized lung tissue was sonicated in buffer containing 5% 1 M Tris-HCl, pH 7.5; 1% 100 mM EGTA; 0.2% 500 mM EDTA with Complete Miniprotease inhibitor cocktail tablet (Roche Diagnostics, Mannheim, Germany), and 1% PMSF with a Fisher Sonic Dismembrator Model 300 using a micro-tip operated at 35%. The homogenate was centrifuged at 20,000 g for 15 minutes and 50 µg of protein from the supernatant was electrophoresed on a SDS/PAGE gel under non-reducing conditions. Following electrophoresis, proteins were transferred to nitrocellulose paper and immunoblot analysis was performed with antisera against rabbit polyclonal ABCA3 (kind gift from Dr T. Weaver, Cincinnati Children's Hospital Medical Center). Incubation in goat anti-rabbit (heavy and light chain) peroxidase-conjugate (Calbiochem, La Jolla, CA) was used to detect the antigen-antibody complexes.
For detection of FAS, RNA was treated with DNase inactivation reagent (Ambion, Austin, TX) before cDNA synthesis. DNase-treated total-lung RNA (10 µg) was reverse transcribed into cDNA using oligo (dT) and analyzed by real-time PCR with the Smart Cycler System (Cepheid, Sunnyvale, CA). The relative concentration of FAS mRNA was standardized to the internal control ß-actin. Primers used to quantify ß-actin mRNA were 5'-TGG AAT CCT GTG GCA TCC ATG AAC-3' and 5'-TAA AAC GCA GCT CAG TAA CAG TCC G-3', and to quantify FAS mRNA were 5'-GGA CAT GGT CAC AGA CGA TGA C-3' and 5'-GTC GAA CTT GGA CAG ATC CTT CA-3'.
Transient transfection of promoter constructs
Promoter-luciferase constructs (see Table S1 in the supplementary material) were co-transfected with increasing amounts of pCMV5-C/EBP
(0, 0.05,
0.1 and 0.4 pmol) into HeLa and H441 cells. Mouse FOXA2 promoter luciferase
construct was kindly provided by Dr K. Kaestner, University of Pennsylvania
School of Medicine. FuGENE 6 (Roche Molecular Biochemicals, Indianapolis, IN)
was used for transfection in accordance with the manufacturer's
specifications. Forty-eight hours following transfection, luciferase activity
was assessed and normalized for co-transfection by ß-galactosidase
activity. All transfections were performed in triplicate.
Quantitative analysis
Immunoreactive bands were detected with enhanced chemiluminescence reagents
(Amersham, Chicago, IL) and band intensities were quantified by densitometry
(ImageQuant v5.2, GE Healthcare, Piscataway, NJ). Statistical differences were
determined using unpaired Student's t-tests. Comparisons among groups
were assessed by Analysis of Variance (ANOVA) with Tukey's tests used for
post-hoc analyses. Results were expressed as mean±s.e.m. Differences
were considered significant at the 5% level.
| RESULTS |
|---|
|
|
|---|
/
mice. Analysis of genotyped litters
at E18.5 demonstrated Mendelian inheritance, indicating no fetal loss related
to the Cebpa
/
alleles.
SP-C-rtTA/tg, (tetO)7Cre/tg,
Cebpaflox/flox dams (n=24 litters) were
maintained on doxycycline from E0. Pups were genotyped between E16.5 and P1.
At birth, body weights and lung weights of control and
Cebpa
/
mice were similar: 1.73±0.06 g
versus 1.71±0.06 g (P>0.05) and 53.1±3.2 mg versus
49.9±3.9 mg (P>0.05), respectively. Blood glucose
concentrations in Cebpa
/
mice were similar
to control littermates at birth: 127±6 mg/dl versus 132±7 mg/dl
(P>0.05).
The extent of Cebpa gene deletion in respiratory epithelial cells
in Cebpa
/
mice was assessed the day before
birth (E18.5), demonstrating extensive reduction of Cebpa by
immunohistochemistry. C/EBP
was detected in alveolar type II cells in
littermate controls throughout the respiratory epithelium at E16.5 (data not
shown), E18.5 (Fig. 1A) and P1
(data not shown), consistent with previous findings
(Alam et al., 1992
;
Sugahara et al., 2001
). By
contrast, nuclear staining of C/EBP
was generally absent in terminal
lung saccules of Cebpa
/
mice
(Fig. 1B).
C/EBP
is required for pulmonary maturation in late gestation
When observed during normal delivery (E19.5-E21), control mice became
oxygenated and survived normally. Cebpa
/
mice developed severe respiratory distress and generally died within 2-3 hours
of birth. Histological examination of Cebpa
/
pups revealed extensive atelectasis and pulmonary congestion (data not shown),
findings consistent with impaired maturation of the respiratory epithelium.
During the saccular period (E17.5E18.5) of fetal lung morphogenesis,
the terminal lung buds dilate, the mesenchyme and epithelium thin, and
extensive ingrowth of pulmonary capillaries invades in close proximity to
squamous respiratory epithelial cells (type I cells) as the gas exchange
surface of the lung forms. At E18.5, the peripheral lung of control mice
consisted of saccules lined by both squamous type I cells and cuboidal type II
cells, indicating structural maturation typical at this stage of gestation
(Fig. 2A). By contrast,
dilation of peripheral saccules was reduced, the mesenchyme remained
thickened, and the peripheral saccules were lined by a cuboidal epithelium
that lacked squamous type I cells in the lungs of
Cebpa
/
mice
(Fig. 2B), findings consistent
with pulmonary immaturity.
|
|
/
mice showed increased
levels of PAS staining in bronchiolar epithelium, indicated by the red deposit
(Fig. 2D), compared with their
control littermates (Fig.
2C).
At the ultrastructural level, lungs from E18.5
Cebpa
/
mice were immature compared with
their littermates. In controls, cuboidal type II cells contained numerous
lamellar bodies, apical microvilli and highly organized rosette glycogen
(Fig. 2E,F). Lamellar bodies
and secreted surfactant were observed in the lumen of peripheral airspaces at
E18.5. By contrast, cytoplasmic glycogen was dispersed and apical microvilli
were smaller in type II epithelial cells lining the immature lung tubules of
Cebpa
/
mice
(Fig. 2G,H). Squamous type I
cells were lacking and the extent of capillary invasion was decreased.
Lamellar bodies, the intracellular storage form of pulmonary surfactant, were
absent in type II cells, and secreted surfactant was not detected in the
airspaces of Cebpa
/
mice at E18.5.
|
/
mice
/
mice, the cuboidal epithelium of the
peripheral lung saccules expressed FOXA1 and TTF1, in a relatively homogenous
pattern, indicating a lack of squamous type I cells and the predominance of
immature cuboidal epithelial cells that is characteristic of earlier stages of
lung morphogenesis (Fig. 3B,D).
Aquaporin 5 staining, a selective marker of squamous type I cells, was
decreased in the peripheral lung saccules of
Cebpa
/
mice
(Fig. 3F), consistent with
pulmonary immaturity.
Expression of surfactant proteins, SP-A, SP-B, SP-C and SP-D in type II
epithelial cells in the peripheral lung normally increases prior to birth
(Randell and Young, 2004
). Of
these, SP-B and SP-C play crucial roles in surfactant function and homeostasis
(Clark et al., 1995
;
Clark et al., 2001
;
Ikegami et al., 2003
;
Shulenin et al., 2004
). Mature
SP-B and proSP-C staining was decreased in conducting airways and peripheral
lung saccules in the lungs of Cebpa
/
mice
(Fig. 4B,D), demonstrating that
normal pulmonary epithelial cell differentiation and expression of surfactant
proteins are dependent upon C/EBP
.
In contrast to the inhibitory effect of Cebpa deletion on differentiation of the peripheral lung, no abnormalities in formation or differentiation of epithelial cells in conducting airways was observed. Morphology and expression of CCSP, a non-ciliated secretory cell bronchial marker, and Foxj1, a ciliated cell marker, were not altered in conducting airways at sites of Cebpa deletion (data not shown).
C/EBP
is required in synthesis of surfactant lipids and proteins
Pulmonary surfactant is required in lung function. Lung Sat PC, a crucial
component of pulmonary surfactant, and FAS, a major precursor of fatty acid
synthesis in the lung, normally increases before birth
(Das, 1980
;
Pope and Rooney, 1987
;
Sa et al., 1990
;
Stahlman et al., 1996
). In
Cebpa
/
mice at E18.5, Sat PC and FAS
expression were significantly decreased, whereas the fractional content of PC
and other minor phospholipid components were unaltered in the lungs of
Cebpa
/
mice
(Table 1). Likewise, levels of
SP-A, SP-B, SP-C and SP-D mRNAs (Fig.
5A) and proteins (Fig.
5B) were significantly decreased in
Cebpa
/
mice, consistent with
immunohistochemical findings.
|
|
|
/
mice at E18.5, ABCA3 protein levels
were significantly decreased (Fig.
5C). As lack of either SP-B or ABCA3 causes respiratory failure at
birth (Clark et al., 1995
/
mice.
Vascular and smooth muscle development in lungs of Cebpa
/
mice
vWF staining was used to identify the pulmonary capillary bed at E18.5. In
control lungs at E18.5, an extensive vascular network associated with thinning
of the walls of the peripheral saccules was observed
(Fig. 6A). By contrast, vWF
staining revealed a relatively undeveloped capillary bed, consistent with the
generalized immaturity of the lung in Cebpa
/
mice. vWF stained vessels were embedded within the thickened mesenchyme of the
immature lung saccules (Fig.
6B). There was no evidence of hemorrhage.
-SMA staining, a
marker for pulmonary arteries and bronchial smooth muscle was similar in
control and Cebpa
/
lungs
(Fig. 6C,D), suggesting that
the deletion of Cebpa did not inhibit pulmonary smooth muscle cell
differentiation.
Expression of Cebpb and Cebpd in Cebpa
/
mice
Because C/EBP
, C/EBPß and C/EBP
are closely related bZIP
transcription factors that are co-expressed in respiratory epithelial cells,
they may serve agonistic or antagonistic roles at specific transcriptional
targets in the lung. Expression of C/EBP
was significantly reduced;
however, levels of C/EBPß and C/EBP
mRNA in
Cebpa
/
mice were comparable with control
littermates (Fig. 7).
|
|
regulates gene expression: RNA microarray analysis
/
mice were compared at E18.5 using
Affymetrix murine genome MOE430 gene chips. One hundred and twelve genes were
identified that were significantly altered after deletion of Cebpa.
Among them, 64 mRNAs were increased and 48 mRNAs were decreased in response to
the deletion of Cebpa in the lung (see Table S2 in the supplementary
material). Selected genes are shown in a heat map (see Fig. S1 in the
supplementary material). Differentially expressed genes were classified
according to Gene Ontology (GO) classification on Biological Process. The
Fisher Exact Test was used to calculate the probability of each category that
was over-represented in the selected list using the entire MOE430 mouse genome
as a reference dataset. Genes involved in lipid metabolism
(P=1x107) and fatty acid metabolism
(P=4x105) were markedly decreased in lungs of
Cebpa
/
mice. Genes regulating related
biological processes, including lipid biosynthesis and lipid catabolism, were
also decreased in lungs of Cebpa
/
mice
(P<0.05), demonstrating that Cebpa plays a crucial role
in the regulation of genes influencing lipid homeostasis in the lung. By
contrast, expression of genes involved in muscle contraction
(P=8x107), morphogenesis
(P=2x106), and growth and development
(P=1x105) was significantly increased in
response to the deletion of Cebpa (see Table S3 in the supplementary
material).
As pulmonary maturation is delayed in
Cebpa
/
mice, we queried the microarray to
retrieve factors involved in lung epithelial cell differentiation. TGFß2
mRNA was increased in the lungs of Cebpa
/
mice. Consistently, intensity and numbers of cells immunostained for
TGFß2 was increased in the lungs of
Cebpa
/
mice at E18.5
(Fig. 8). Growth factor
signaling is an essential component of the regulatory network controlling
proliferation, differentiation and pattern formation of the lung
(Cardoso et al., 1997
;
Yano et al., 2000
;
Mason et al., 2003
;
Portnoy et al., 2004
). As
TGFß2 signaling is known to inhibit lung maturation and type II cell
differentiation (Whitsett et al.,
1992
; Lebeche et al.,
1999
), effects of Cebpa deletion may be mediated in part
by increased expression of TGFß2.
As FOXA2 and TTF1 regulate expression of surfactant proteins and deletion
of either Foxa2 or mutations in Titf1 delays lung maturation
and causes respiratory failure at birth
(Minoo et al., 1999
;
Cassel and Nord, 2003
;
Wan et al., 2004
), we sought
to determine whether these genes share transcriptional targets or participate
in regulatory programs crucial for lung differentiation at birth. Comparison
of mRNA profiles in lung tissue from Cebpa
/
,
Foxa2
/
(Wan et al., 2004
),
Titf1PM/PM (deFelice
et al., 2003
) (phosphorylation mutant) mice at E18.5 demonstrated
that a number of mRNAs and their biological processes were shared, compared
with age-matched control littermates (data not shown). Genes involved in the
regulation of lung lipid homeostasis (Lrp2, Sftpb, Ldlr, Abca3, Dlk1,
Scd1 and Pon1) and inflammation (Sftpa1, Hc and
Lyzs) were decreased in response to the selective deletion of either
Cebpa, Foxa2 or mutation of Titf1 in the respiratory
epithelium. To test whether Foxa2 or Titf1 were required for
expression of C/EBP
in respiratory epithelial cells,
immunohistochemistry for C/EBP
was assessed in the lungs from
Titf1/
(Kimura et al., 1996
) and
Foxa2
/
(Wan et al., 2004
) transgenic
mice at E18.5. C/EBP
immunostaining was markedly decreased or absent in
the respiratory epithelium of mutant Titf1/
and was decreased in Foxa2
/
mice
(Fig. 9), providing evidence
that normal expression of C/EBP
is dependent upon both Foxa2
and Titf1.
|
|
|
target genes in vitro
on target gene expression was
induced by transcriptional activation, co-transfection experiments were
performed using promoter constructs expressing luciferase under control of
several genes regulating surfactant homeostasis in vitro. C/EBP
enhanced activities of Sftpa, Sftpb, Sftpc and Abca3
promoters in HeLa cells in vitro (Fig.
10).
mRNA analysis demonstrated that FOXA2 expression was decreased in lungs
from Cebpa
/
mice in vivo
(Fig. 11A). Therefore, the
potential role of C/EBP
on Foxa2 promoter activity was
assessed in vitro. C/EBP
increased the activity of a reporter construct
containing 1.6 kb of the promoter region of Foxa2 in a dose-dependent
manner in both HeLa (Fig. 11B)
and H441 pulmonary adenocarcinoma cells
(Fig. 11C). Thus, C/EBP
may influence perinatal lung maturation by activating surfactant protein gene
expression or by regulating FOXA2 expression, the latter also required for
normal lung function (Wan et al.,
2004
). Conversely, C/EBP
staining was decreased in the
lungs of mice in which Foxa2 was selectively deleted
(Fig. 9D), supporting the
concept that each gene influences expression of the other, indicating that
Cebpa and Foxa2 participate in a network regulating
perinatal lung maturation.
| DISCUSSION |
|---|
|
|
|---|
/
mice
were euglycemic but, nevertheless, died from respiratory failure after birth,
demonstrating its crucial role in perinatal lung function. Normal expression
of C/EBP
was dependent upon TTF1 and FOXA2, transcription factors that
play a crucial role in perinatal lung differentiation. C/EBP
regulated
a number of genes influencing surfactant synthesis, some of which were
co-regulated by TTF1 and FOXA2. Thus, Cebpa participates in a
transcriptional network orchestrating perinatal lung maturation and function
at birth.
|
has previously been shown to regulate cell differentiation in
lung cancer cell lines (Halmos et al.,
2002
also plays a crucial role in adipocyte differentiation
(Rosen and Spigelman, 2000
expression
(Li et al., 1995
/
mice. It is unclear, however,
whether reduced lipid synthesis in Cebpa
/
lungs is mediated by a direct inhibitory effect on transcription or by a
generalized delay in lung maturation. Activity of the surfactant protein
promoters was stimulated by C/EBP
in vitro and a marked decrease in
surfactant protein expression was observed in type II cells of
Cebpa
/
mice in vivo, supporting a
cell-autonomous effect of C/EBP
on surfactant protein expression.
Consistent with the anatomic immaturity seen in the
Cebpa
/
mice, alveolar type I cells were
lacking in association with decreased expression of aquaporin 5 (an alveolar
type I cell marker). Delayed vascular invasion suggests that C/EBP
also
influences paracrine or paracellular signaling from the epithelium to the
endothelium.
Branching morphogenesis is unaltered in Cebpa
/
mice
The present findings demonstrate that C/EBP
plays a regulatory role
in maturation of the lung in late gestation but is not required for branching
morphogenesis. TTF1, a transcription factor required for branching
morphogenesis of the embryonic lung
(Stahlman et al., 1996
;
Minoo et al., 1999
;
Cassel and Nord, 2003
), was
not altered in Cebpa
/
mice. This is
consistent with the developmental pattern of C/EBP
which increases in
late gestation in temporal proximity to alveolar type II cell differentiation
(Li et al., 1995
;
Rosenberg et al., 2002
).
C/EBP
is required for surfactant synthesis at birth
SP-B and ABCA3 are required for transition to air breathing at birth.
Mutations in either gene cause respiratory failure in human infants
(Clark et al., 1995
;
Shulenin et al., 2004
;
Whitsett et al., 2004
).
Targeted disruption of Sftpb in mice and mutations in ABCA3
in humans impaired formation of lamellar bodies and caused respiratory
distress because of the lack of pulmonary surfactant
(Nogee et al., 2000
;
Randell and Young, 2004
;
Shulenin et al., 2004
). In the
lungs of Cebpa
/
mice, lamellar bodies were
absent, and levels of surfactant proteins and ABCA3 were significantly
decreased. Lack of surfactant phospholipid, SP-B and ABCA3, as well as the
structural immaturity of the lung, are probably sufficient to account for
perinatal respiratory failure seen after deletion of Cebpa.
Distinct roles of Cebpa, Cebpb and Cebpd in regulating gene expression
C/EBP
, C/EBPß and C/EBP
transcription factors exhibit
highly conserved regions of amino acid sequence identity to the bZIP
DNA-binding domain and demonstrate overlapping patterns of spatial expression
(He and Crouch, 2002
;
Ramji and Foka, 2002
;
Rosenberg et al., 2002
).
Furthermore, these transcription factors can homo- or heterodimerize to
regulate transcription (Lekstrom-Himes and
Xanthopoulos, 1998
). Therefore, C/EBP
, C/EBPß and
C/EBP
may compete or serve complementary roles at specific
translational targets. C/EBP
, C/EBPß and C/EBP
were shown
to transcriptionally activate expression of SP-A
(Matlapudi et al., 2002
;
Rosenberg et al., 2002
) and
SP-D (He and Crouch, 2002
) in
vitro. However, expression of C/EBPß and C/EBP
was unchanged in
the Cebpa
/
mice; therefore, it is unclear
whether maintenance of C/EBPß and C/EBP
plays a role in the
phenotypic changes observed in the lung.
Role of Tgfb2 in Cebpa
/
mice
Growth factors play important roles in mammalian development, including
lung epithelial cell proliferation and differentiation. Deletion of
Cebpa enhanced expression of TGFß2 in the respiratory
epithelium. Increased expression of TGFß inhibited lung maturation in
late gestation (Zhou et al.,
1996
; Bartram and Speer,
2004
) and inhibited expression of surfactant synthesis
(Whitsett et al., 1992
;
Jaskoll et al., 1996
). SMAD3
is a transcription factor mediating TGFß signaling
(Massagué, 1998
;
Attisano and Wrana, 2000
;
Shi and Massagué,
2003
). The expression of both TGFß2 and SMAD3 was increased
in Cebpa
/
mice, providing a potential
mechanism by which Cebpa influences pulmonary maturation and
surfactant synthesis.
Overlapping roles of the Cebpa, Foxa2 and Titf1 genes
Deletion of Cebpa inhibited expression of a number of genes
involved in host defense and lipid metabolism, including several genes
identified as Cebpa targets during acute phase responses
(Burgess-Beusse and Darlington,
1998
) and adipogenesis (Tong
et al., 2005
). Sftpa, Sftpb, Lys, Scd1 and
Slc34a2 were significantly decreased in
Cebpa
/
mice and are selectively expressed in
respiratory epithelial cells (Li et al.,
1995
; Rosenberg et al.,
2002
; Barlier-Mur et al.,
2003
; Cassell and Nord, 2003;
Zhang et al., 2004
). The
increased expression of these genes correlates temporally with increased
C/EBP
expression that occurs prior to birth
(Li et al., 1995
;
Rosenberg et al., 2002
).
Surfactant proteins, lysozyme, Scd1 (Stearoyl-coenzyme A desaturase 1) and
Slc34a2 [solute carrier family 34 (sodium phosphate, member 2)] were decreased
in lungs of mice bearing mutations in phosphorylation sites in Titf1,
and in Cebpa
/
and
Foxa2
/
mice
(deFelice et al., 2003
),
suggesting that these transcription factors influence a group of genes
associated with perinatal lung maturation and function.
This study demonstrated that C/EBP
regulates a group of genes that
mediate lipid synthesis, surfactant homeostasis and host defense required for
postnatal adaptation to air breathing. Targeted deletion of the Cebpa
gene inhibited the differentiation of respiratory epithelial cells, resulting
in decreased surfactant synthesis causing respiratory failure at birth.
C/EBP
, FOXA2, and TTF1 share transcriptional targets crucial for
surfactant synthesis and host defense. The finding that FOXA2 and TTF1 are
required for normal Cebpa gene expression and that C/EBP
regulates Foxa2 gene expression supports the concept that these
factors function in a transcriptional network that regulates genes required
for maturation and function of the lung at birth
(Fig. 12).
|
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
Supplementary material for this article is available at http://dev.biologists.org/cgi/content/full/133/6/1155/DC1
| REFERENCES |
|---|
|
|
|---|
Alam, T., An, M. R. and Papaconstantinou, J.
(1992). Differential expression of three C/EBP isoforms in
multiple tissues during the acute phase response. J. Biol.
Chem. 267,5021
-5024.
Attisano, L. and Wrana, J. L. (2000). Smads as
transcriptional co-modulators. Curr. Opin. Cell Biol.
12,235
-243.[CrossRef][Medline]
Bachurski, C. J., Yang, G. H., Currier, T. A., Gronostajski, R.
M. and Hong, D. (2003). Nuclear factor I/thyroid
transcription factor 1 interactions modulate surfactant protein C
transcription. Mol. Cell. Biol.
23,9014
-9024.
Barlier-Mur, A. M., Chailley-Heu, B., Pinteur, C.,
Henrion-Caude, A., Delacourt, C. and Bourbon, J. R. (2003).
Maturational factors modulate transcription factors CCAAT/enhancer-binding
proteins alpha, beta, delta, and peroxisome proliferator-activated
receptor-gamma in fetal rat lung epithelial cells. Am. J. Respir.
Cell Mol. Biol. 29,620
-626.
Bartlett, G. R. (1959). Phosphorous assay in
column chromatography. J. Biol. Chem.
234,466
-468.
Bartram, U. and Speer, C. P. (2004). The role
of transforming growth factor beta in lung development and disease.
Chest 125,754
-765.
Besnard, V., Wert, S. E., Hull, W. M. and Whitsett, J. A.
(2004). Immunohistochemical localization of Foxa1 and Foxa2 in
mouse embryos and adult tissues. Gene Expr. Patterns
5, 193-208.[CrossRef][Medline]
Birkenmeier, E. H., Gwynn, B., Howard, S., Jerry, J., Gordon, J.
I., Landschulz, W. H. and McKnight, S. L. (1989).
Tissue-specific expression, developmental regulation, and genetic mapping of
the gene encoding CCAAT/enhancer binding protein. Genes
Dev. 3,1146
-1156.
Burgess-Beusse, B. L. and Darlington, G. J.
(1998). C/EBP
is critical for the neonatal acute-phase
response to inflammation. Mol. Cell. Biol.
18,7269
-7277.
Cao, Z., Umek, R. M. and McKnight, S. L.
(1991). Regulated expression of three C/EBP isoforms during
adipose conversion of 3T3-L1 cells. Genes Dev.
5,1538
-1552.
Cardoso, W. V. (2001). Molecular regulation of
lung development. Annu. Rev. Physiol.
63,471
-494.[CrossRef][Medline]
Cardoso, W. V., Itoh, A., Nogawa, H., Mason, I. and Brody, J.
S. (1997). FGF-1 and FGF-7 induce distinct patterns of growth
and differentiation in embryonic lung epithelium. Dev.
Dyn. 208,398
-405.[CrossRef][Medline]
Cassel, T. N. and Nord, M. (2003). C/EBP
transcription factors in lung epithelium. Am. J.
Physiol. 285,L773
-L781.
Clark, J. C., Wert, S. E., Bachurski, C. J., Stahlman, M. T.,
Stripp, B. R., Weaver, T. E. and Whitsett, J. A. (1995).
Targeted disruption of the surfactant protein B gene disrupts surfactant
homeostasis, causing respiratory failure in newborn mice. Proc.
Natl. Acad. Sci. USA 92,7794
-7798.
Clark, J. C., Tichelaar, J. W., Wert, S. E., Itoh, N., Perl, A.
K., Stahlman, M. T. and Whitsett, J. A. (2001). FGF-10
disrupts lung morphogenesis and causes pulmonary adenomas in vivo.
Am. J. Physiol. 280,L705
-L715.
Das, D. K. (1980). Fatty acid synthesis in
fetal lung. Biochem. Biophys. Res. Commun.
92,867
-875.[CrossRef][Medline]
deFelice, M., Silberschmidt, D., DiLauro, R., Xu, Y., Wert, S.
E., Weaver, T. E., Bachurski, C. J., Clark, J. C. and Whitsett, J. A.
(2003). TTF-1 phosphorylation is required for peripheral lung
morphogenesis, perinatal survival, and tissue-specific gene expression.
J. Biol. Chem. 278,35574
-35583.
De Simone, V. and Cortese, R. (1992).
Transcription factors and liver-specific genes. Biochim. Biophys.
Acta 1132,119
-126.[Medline]
Dennis, G., Jr, Sherman, B. T., Hosack, D. A., Yang, J., Gao,
W., Lane, H. C. and Lempicki, R. A. (2003). DAVID: Database
for Annotation, Visualization, and Integrated Discovery. Genome
Biol. 4,P3
.[CrossRef][Medline]
Dranoff, G., Crawford, A. D., Sadelain, M., Ream, B., Rashid,
A., Bronson, R. T., Dickersin, G. R., Bachurski, C. J., Mark, E. L., Whitsett,
J. A. et al. (1994). Involvement of granulocyte-macrophage
colony-stimulating factor in pulmonary homeostasis.
Science 264,713
-716.
Flodby, P., Barlow, C., Kylefjord, H., Ahrlund-Richter, L. and
Xanthopoulos, K. G. (1996). Increased hepatic cell
proliferation and lung abnormalities in mice deficient in CCAAT/enhancer
binding protein alpha. J. Biol. Chem.
271,24753
-24760.
Glasser, S. W., Burhans, M. S., Korfhagen, T. R., Na, C. L.,
Sly, P. D., Ross, G. F., Ikegami, M. and Whitsett, J. A.
(2001). Altered stability of pulmonary surfactant in SP-C
deficient mice. Proc. Natl. Acad. Sci. USA
98,6366
-6371.
Hallman, M. and Gluck, L. (1976).
Phosphatidylglycerol in lung surfactant. III. Possible modifier of surfactant
function. J. Lipid Res.
17,257
-262.[Abstract]
Halmos, B., Huettner, C. S., Kocher, O., Ferenczi, K., Karp, D.
D. and Tenen, D. G. (2002). Down-regulation and
antiproliferative role of C/EBPalpha in lung cancer. Cancer
Res. 62,528
-534.
He, Y and Crouch, E. (2002). Surfactant protein
D gene regulation. Interactions among the conserved CCAAT/enhancer-binding
protein elements. J. Biol. Chem.
277,19530
-19537.
Ikegami, M., Dhami, R. and Schuchman, E. H.
(2003). Alveolar lipoproteinosis in an acid
sphingomyelinase-deficient mouse model of Niemann-Pick disease. Am.
J. Physiol. 284,L518
-L525.
Irizarry, R. A., Bolstad, B. M., Collin, F., Cope, L. M., Hobbs,
B. and Speed, T. P. (2003a). Summaries of Affymetrix GeneChip
probe level data. Nucleic Acids Res.
31, e15.
Irizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D.,
Antonellis, K. J., Scherf, U. and Speed, T. P. (2003b).
Exploration, normalization, and summaries of high density oligonucleotide
array probe level data. Biostatistics
4, 249-264.[Abstract]
Jaskoll, T., Choy, H. A. and Melnick, M.
(1996). The glucocorticoid-glucocorticoid receptor signal
transduction pathway, transforming growth factor-beta, and embryonic mouse
lung development in vivo. Pediatr. Res.
39,749
-759.[Medline]
Kimura, S., Hara, Y., Pineau, T., Fernandez-Salguero, P., Fox,
C. H., Ward, J. M. and Gonzalez, F. J. (1996). The T/ebp null
mouse: thyroid-specific enhancer-binding protein is essential for the
organogenesis of the thyroid, lung, ventral forebrain, and pituitary
Genes Dev. 10,60
-69.
Lebeche, D., Malpel, S. and Cardoso, W. V.
(1999). Fibroblast growth factor interactions in the developing
lung. Mech. Dev. 86,125
-136.[CrossRef][Medline]
Lee, Y. H., Sauer, B., Johnson, P. F. and Gonzalez, F. J.
(1997). Disruption of the c/ebp alpha gene in adult mouse liver.
Mol. Cell. Biol. 17,6014
-6022.[Abstract]
Lekstrom-Himes, J. and Xanthopoulos, K. G.
(1998). Biological role of the CCAAT/enhancer-binding protein
family of transcription factors. J. Biol. Chem.
273,28545
-28548.
Li, F., Rosenberg, E., Smith, C. I., Notarfrancesco, K.,
Reisher, S. R., Shuman, H. and Feinstein, S. I. (1995).
Correlation of expression of transcription factor C/EBP alpha and surfactant
protein genes in lung cells. Am. J. Physiol.
269,L241
-L247.
MacDougald, O. A. and Lane, M. D. (1995).
Transcriptional regulation of gene expression during adipocyte
differentiation. Annu. Rev. Biochem.
64,345
-373.[CrossRef][Medline]
Mason, R. J., Nellenbogen, J. and Clements, J. A.
(1976). Isolation of disaturated phosphatidylcholine with osmium
tetroxide. J. Lipid Res.
17,281
-284.[Abstract]
Mason, R. J., Pan, T., Edeen, K. E., Nielsen, L. D., Zhang, F.,
Longphre, M., Eckart, M. R. and Neben, S. (2003).
Keratinocyte growth factor and the transcription factors C/EBP alpha, C/EBP
delta, and SREBP-1c regulate fatty acid synthesis in alveolar type II cells.
J. Clin. Invest. 112,244
-255.[CrossRef][Medline]
Massagué, J. (1998). TGF-beta signal
transduction. Annu. Rev. Biochem.
67,753
-791.[CrossRef][Medline]
Matlapudi, A., Wang, M., Rosenberg, E., Ewing, J. R. and
Feinstein, S. I. (2002). A role for C/EBP delta in human
surfactant protein A (SP-A) gene expression. Biochim. Biophys.
Acta 1575,91
-98.[Medline]
Minoo, P., Su, G., Drum, H., Bringas, P. and Kimura, S.
(1999). Defects in tracheoesophageal and lung morphogenesis in
Nkx2.1(/) mouse embryos. Dev. Biol.
209, 60-71.[CrossRef][Medline]
Morrisey, E. E., Ip, H. S., Lu, M. M. and Parmacek, M. S.
(1996). GATA-6: a zinc finger transcription factor that is
expressed in multiple cell lineages derived from lateral mesoderm.
Dev. Biol. 177,309
-322.[CrossRef][Medline]
Mucenski, M. L., Wert, S. E., Nation, J. M., Loudy, D. E.,
Huelsken, J., Birchmeier, W., Morrisey, E. E. and Whitsett, J. A.
(2003). beta-Catenin is required for specification of
proximal/distal cell fate during lung morphogenesis. J. Biol.
Chem. 278,40231
-40238.
Nogee, L. M., Wert, S. E., Proffit, S. A., Hull, W. M. and
Whitsett, J. A. (2000). Allelic heterogeneity in hereditary
surfactant protein B (SP-B) deficiency. Am. J. Respir. Crit. Care
Med. 161,973
-981.
Nord, M., Lag, M., Cassel, T. N., Randmark, M., Becher, R.,
Barnes, H. J., Schwarze, P. E., Gustafsson, J. A. and Lund, J.
(1998). Regulation of CCSP (PC-BP/uteroglobin) expression in
primary cultures of lung cells: involvement of C/EBP. DNA Cell
Biol. 17,481
-492.[Medline]
Perl, A. K., Tichelaar, J. W. and Whitsett, J. A.
(2002). Conditional gene expression in the respiratory epithelium
of the mouse. Transgenic Res.
11, 21-29.[CrossRef][Medline]
Perl, A. K. T., Wert, S. E., Loudy, D. E., Shan, Z., Blair, P.
A. and Whitsett, J. A. (2005). Conditional recombination
reveals distinct subsets of epithelial cells in trachea, bronchi, and alveoli.
Am. J. Respir. Cell Mol. Biol.
33,455
-462.
Pope, T. S. and Rooney, S. A. (1987). Effects
of glucocorticoid and thyroid hormones on regulatory enzymes of fatty acid
synthesis and glycogen metabolism in developing fetal rat lung.
Biochim. Biophys. Acta.
918,141
-148.[Medline]
Portnoy, J., Curran-Everett, D. and Mason, R. J.
(2004). Keratinocyte growth factor stimulates alveolar type II
cell proliferation through the extracellular signal-regulated kinase and
phosphatidylinositol 3-OH pathways. Am. J. Respir. Cell Mol.
Biol. 30,901
-907.
Ramji, D. P. and Foka, P. (2002).
CCAAT/enhancer-binding proteins: structure, function and regulation.
Biochem. J. 365,561
-575.[Medline]
Randell, S. H. and Young, S. L. (2004). In
Fetal and Neonatal Physiology (ed. R. A. Polin, W. W.
Fox and S. H. Abman), pp. 1034-1040. Philadelphia:
Saunders.
Ridsdale, R. and Post, M. (2004). Surfactant
lipid synthesis and lamellar body formation in glycogen-laden type II cells.
Am. J. Physiol. 287,L743
-L751.
Rosen, E. D. and Spigelman, B. M. (2000).
Molecular regulation of adipogenesis. Annu. Rev. Cell Dev.
Biol. 16,145
-171.[CrossRef][Medline]
Rosenberg, E., Li, F., Reisher, S. R., Wang, M., Gonzales, L.
W., Ewing, J. R., Malek, S., Ballard, P. L., Notarfrancesco, K., Shuman, H. et
al. (2002). Members of the C/EBP transcription factor family
stimulate expression of the human and rat surfactant protein A (SP-A) genes.
Biochim. Biophys. Acta
1575,82
-90.[Medline]
Sa, G., Das, T. and Mukherjea, M. (1990).
Relationship between fatty acid synthesis, transport and total lipid content
during human fetal lung development. Indian J. Biochem.
Biophys. 27,43
-47.[Medline]
Shi, Y. and Massague, J. (2003). Mechanisms of
TGF-beta signaling from cell membrane to the nucleus.
Cell 113,685
-700.[CrossRef][Medline]
Shulenin, S., Nogee, L. M., Annilo, T., Wert, S. E., Whitsett,
J. A. and Dean, M. (2004). ABCA3 gene mutations in
newborns with fatal surfactant deficiency. N. Engl. J.
Med. 350,1296
-1303.
Stahlman, M. T., Gray, M. E. and Whitsett, J. A.
(1996). Expression of thyroid transcription factor-1 (TTF-1) in
fetal and neonatal human lung. J. Histochem. Cytochem.
44,673
-678.[Abstract]
Stahlman, M. T., Gray, M. E., Hull, W. M. and Whitsett, J.
A. (2002). Immunolocalization of surfactant protein-D (SP-D)
in human fetal, newborn, and adult tissues. J. Histochem.
Cytochem. 50,651
-660.
Sugahara, K., Sadohara, T., Sugita, M., Iyama, K. and Takiguchi,
M. (1999). Differential expression of CCAAT enhancer binding
protein family in rat alveolar epithelial cell proliferation and in acute lung
injury. Cell Tissue Res.
297,261
-270.[CrossRef][Medline]
Sugahara, K., Iyama, K., Kimura, T., Sano, K., Darlington, G.
J., Akiba, T. and Takiguchi, M. (2001). Mice lacking
CCAAT/enhancer binding protein-
show hyperproliferation of alveolar
type II cells and increased surfactant protein mRNAs. Cell Tissue
Res. 306,57
-63.[CrossRef][Medline]
Takiguchi, M. (1998). The C/EBP family of
transcription factors in the liver and other organs. Int. J. Exp.
Pathol. 79,369
-391.[CrossRef][Medline]
Tong, Q., Tsai, J., Tan, G., Dalgin, G. and Hotamisligil, G.
S. (2005). Interaction between GATA and the C/EBP family of
transcription factors is critical in GATA-mediated suppression of adipocyte
differentiation. Mol. Cell. Biol.
25,706
-715.
Tusher, V. G., Tibshirani, R. and Chu, G.
(2001). Significance analysis of microarrays applies to the
ionizing radiation response. Proc. Natl. Acad. Sci.
USA 98,5116
-5121.
Wan, H., Xu, Y., Ikegami, M., Stahlman, M. T., Kaestner, K. H.,
Ang, S. L. and Whitsett, J. A. (2004). Foxa2 is required for
transition to air breathing at birth. Proc. Natl. Acad. Sci.
USA 101,14449
-14454.
Wan, H., Dingle, S., Xu, Y., Besnard, V., Kaestner, K. H., Ang,
S. L., Wert, S., Stahlman, M. T. and Whitsett, J. A. (2005).
Compensatory roles of Foxa1 and Foxa2 during lung morphogenesis. J.
Biol. Chem. 280,13809
-13816.
Wang, N. D., Finegold, M. J., Bradley, A., Ou, C. N.,
Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R. and Darlington,
G. J. (1995). Impaired energy homeostasis in C/EBP alpha
knockout mice. Science
269,1108
-1112.
Whitsett, J. A., Budden, A., Hull, W. M., Clark, J. C. and
O'Reilly, M. A. (1992). Transforming growth factor-beta
inhibits surfactant protein A expression in vitro. Biochim.
Biophys. Acta 1123,257
-262.[Medline]
Whitsett, J. A., Wert, S. E. and Trapnell, B. C.
(2004). Genetic disorders influencing lung formation and function
at birth. Hum. Mol. Genet.
13,R207
-R215.
Xu, Y., Clark, J. C., Aronow, B. J., Dey, C. R., Liu, C.,
Wooldridge, J. L. and Whitsett, J. A. (2003). Transcriptional
adaptation to cystic fibrosis transmembrane conductance regulator deficiency.
J. Biol. Chem. 278,7674
-7682.
Yano, T., Mason, R. J., Pan, T., Deterding, R. R., Nielsen, L.
D. and Shannon, J. M. (2000). KGF regulates pulmonary
epithelial proliferation and surfactant protein gene expression in adult rat
lung. Am. J. Physiol.
279,L1146
-L1158.
Zhang, F., Pan, T., Nielsen, L. D. and Mason, R. J.
(2004). Lipogenesis in fetal rat lung: importance of C/EBPalpha,
SREBP-1c, and stearoyl-CoA desaturase. Am. J. Respir. Cell Mol.
Biol. 30,174
-183.
Zhou, L., Dey, C. R., Wert, S. E. and Whitsett, J. A.
(1996). Arrested lung morphogenesis in transgenic mice bearing an
SP-C-TGF-ß1 chimeric gene. Dev. Biol.
175,227
-238.[CrossRef][Medline]
Related articles in Development:
This article has been cited by other articles:
![]() |
Y. Xu, C. Saegusa, A. Schehr, S. Grant, J. A. Whitsett, and M. Ikegami C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia Am J Physiol Lung Cell Mol Physiol, August 1, 2009; 297(2): L286 - L298. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Ho, T. A. Alonzo, R. B. Gerbing, J. Pollard, D. L. Stirewalt, C. Hurwitz, N. A. Heerema, B. Hirsch, S. C. Raimondi, B. Lange, et al. Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group Blood, June 25, 2009; 113(26): 6558 - 6566. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Besnard, S. E. Wert, M. T. Stahlman, A. D. Postle, Y. Xu, M. Ikegami, and J. A. Whitsett Deletion of Scap in Alveolar Type II Cells Influences Lung Lipid Homeostasis and Identifies a Compensatory Role for Pulmonary Lipofibroblasts J. Biol. Chem., February 6, 2009; 284(6): 4018 - 4030. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Koschmieder, B. Halmos, E. Levantini, and D. G. Tenen Dysregulation of the C/EBP{alpha} Differentiation Pathway in Human Cancer J. Clin. Oncol., February 1, 2009; 27(4): 619 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Kho, S. Bhattacharya, B. H. Mecham, J. Hong, I. S. Kohane, and T. J. Mariani Expression Profiles of the Mouse Lung Identify a Molecular Signature of Time-to-Birth Am. J. Respir. Cell Mol. Biol., January 1, 2009; 40(1): 47 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Saini, J. R. Harkema, and J. J. LaPres HIF1{alpha} Is Essential for Normal Intrauterine Differentiation of Alveolar Epithelium and Surfactant Production in the Newborn Lung of Mice J. Biol. Chem., November 28, 2008; 283(48): 33650 - 33657. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tomita, T. Kido, R. Kurotani, S.-i. Iemura, E. Sterneck, T. Natsume, C. Vinson, and S. Kimura CAATT/Enhancer-binding Proteins {alpha} and {delta} Interact with NKX2-1 to Synergistically Activate Mouse Secretoglobin 3A2 Gene Expression J. Biol. Chem., September 12, 2008; 283(37): 25617 - 25627. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wan, F. Luo, S. E. Wert, L. Zhang, Y. Xu, M. Ikegami, Y. Maeda, S. M. Bell, and J. A. Whitsett Kruppel-like factor 5 is required for perinatal lung morphogenesis and function Development, August 1, 2008; 135(15): 2563 - 2572. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ikegami, A. Falcone, and J. A. Whitsett STAT-3 regulates surfactant phospholipid homeostasis in normal lung and during endotoxin-mediated lung injury J Appl Physiol, June 1, 2008; 104(6): 1753 - 1760. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. McCurnin, S. Seidner, L.-Y. Chang, N. Waleh, M. Ikegami, J. Petershack, B. Yoder, L. Giavedoni, K. H. Albertine, M. J. Dahl, et al. Ibuprofen-Induced Patent Ductus Arteriosus Closure: Physiologic, Histologic, and Biochemical Effects on the Premature Lung Pediatrics, May 1, 2008; 121(5): 945 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Besnard, Y. Xu, and J. A. Whitsett Sterol response element binding protein and thyroid transcription factor-1 (Nkx2.1) regulate Abca3 gene expression Am J Physiol Lung Cell Mol Physiol, December 1, 2007; 293(6): L1395 - L1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Kramer, G. H. Deutsch, M. A. Sartor, W. D. Hardie, M. Ikegami, T. R. Korfhagen, and T. D. Le Cras Perinatal increases in TGF-{alpha} disrupt the saccular phase of lung morphogenesis and cause remodeling: microarray analysis Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L314 - L327. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tian, R. Zhou, J. E. Rehg, and S. Jackowski Role of Phosphocholine Cytidylyltransferase {alpha} in Lung Development Mol. Cell. Biol., February 1, 2007; 27(3): 975 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Maeda, V. Dave, and J. A. Whitsett Transcriptional Control of Lung Morphogenesis Physiol Rev, January 1, 2007; 87(1): 219 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, N. Rath, S. Hannenhalli, Z. Wang, T. Cappola, S. Kimura, E. Atochina-Vasserman, M. M. Lu, M. F. Beers, and E. E. Morrisey GATA and Nkx factors synergistically regulate tissue-specific gene expression and development in vivo Development, January 1, 2007; 134(1): 189 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Berg, L. Didon, and M. Nord Ectopic expression of C/EBP{alpha} in the lung epithelium disrupts late lung development Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L683 - L693. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||